FTC to block Amgen's deal to buy Horizon - Bloomberg News

Horizon Therapeutics

16/05/2023 01:52

May 15 (Reuters) - The US Federal Trade Commission (FTC)
is expected to file a lawsuit on Tuesday to block Amgen Inc's
 AMGN.O  $27.8 billion deal to buy Horizon Therapeutics PLC
 HZNP.O , citing risks to competition in drug development,
Bloomberg News reported on Monday.

 (Reporting by Akanksha Khushi in Bengaluru; editing by Uttaresh
Venkateshwaran)
 ((Akanksha.Khushi@thomsonreuters.com;))